AeroLeads people directory · profile

Christopher Matheny Email & Phone Number

VP, Development Leader | Rare Disease, Oncology, Immuno-Inflammation | Clinical Development at INOVIO Pharmaceuticals, Inc.
Location: King Of Prussia, Pennsylvania, United States 8 work roles 2 schools
1 work email found @candeltx.com 3 phones found area 484 and 208 LinkedIn matched
✓ Verified May 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 3 phones

Work email c****@candeltx.com
Direct phone (484) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Role
VP, Development Leader | Rare Disease, Oncology, Immuno-Inflammation | Clinical Development
Location
King Of Prussia, Pennsylvania, United States

Who is Christopher Matheny? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Christopher Matheny is listed as VP, Development Leader | Rare Disease, Oncology, Immuno-Inflammation | Clinical Development at INOVIO Pharmaceuticals, Inc., based in King Of Prussia, Pennsylvania, United States. AeroLeads shows a work email signal at candeltx.com, phone signal with area code 484, 208, and a matched LinkedIn profile for Christopher Matheny.

Christopher Matheny previously worked as VP Program Lead at Inovio Pharmaceuticals, Inc. and Consultant, Drug Development and Strategy at Cunningham & Matheny Llc. Christopher Matheny holds Phd, Pharmaceutics from University Of North Carolina At Chapel Hill.

Company email context

Email format at INOVIO Pharmaceuticals, Inc.

This section adds company-level context without repeating Christopher Matheny's masked contact details.

{first_initial}{last}@candeltx.com
86% confidence

AeroLeads found 1 current-domain work email signal for Christopher Matheny. Compare company email patterns before reaching out.

Profile bio

About Christopher Matheny

Strategic clinical drug developer (PharmD, PhD) with 20 years of experience leading global matrix teams in oncology (11+ years), immuno-inflammatory, and musculoskeletal diseases. Proven track record developing oncolytic viruses, monoclonal antibodies, and small molecules in complex and competitive environments. As a Program Leader for 15 years, I spearheaded the development of preclinical through phase 2 programs and provided advisory support for late-stage programs. With extensive enterprise leadership experience, I excel in creating end-to-end drug development strategies, fostering collaboration, and driving clinical execution to advance transformational medicines and optimize organizational success.

Listed skills include Clinical Development, Clinical Research, Clinical Pharmacology, Biopharmaceuticals, and 9 others.

Current workplace

Christopher Matheny's current company

Company context helps verify the profile and gives searchers a useful next step.

INOVIO Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc.
VP, Development Leader | Rare Disease, Oncology, Immuno-Inflammation | Clinical Development
AeroLeads page
8 roles · 29 years

Christopher Matheny work experience

A career timeline built from the work history available for this profile.

Consultant, Drug Development And Strategy

Cunningham & Matheny Llc

I bring over two decades of drug development strategy and implementation expertise, specializing in oncology, immuno-inflammatory, and musculoskeletal indications, including 15 years experience as a global program leader and enterprise leader at both large pharma and small biotech organizations.

Mar 2024 - Sep 2024

Vp, Development Leader

Needham, Massachusetts, US

VP of Development and Executive Leadership Team member of a growing biotech with a preclinical through phase 3 pipeline of viral immunotherapies for cancer; role was broad and diverse, spanning high-level corporate strategy, hands-on program leadership, and expanding internal capabilities and external resources to support pipeline progression.

Mar 2021 - Dec 2023

Asset Leader, Oncology Clinical Development

Brentford, Middlesex, GB

Early Development Leader (EDL) for multiple biologic and NCE immuno-oncology assets, including GSK4074386 (anti-LAG-3 mAb), GSK21795091 (TLR4 agonist), GSK2849330 (anti-HER3 mAb), and undisclosed targets in GSK's Immuno-Oncology Unit. 'Asset CEO', accountable for strategic direction, creation and delivery of clinical development plan, and matrix team.

Feb 2012 - Mar 2021

Director Of Translational Medicine, Biopharmaceuticals

Brentford, Middlesex, GB

Project leader, clinical matrix team leader for multiple preclinical and clinical stage mAb programs, including anti-GM-CSF (ulcerative colitis), myostatin (muscle wasting), and ADAMTS5 (osteoarthritis)

Feb 2008 - Jan 2012

Senior Clinical Pharmacokineticist

Brentford, Middlesex, GB

Contributor to 3 Candidate Selections, 5 INDs, 5 FTIH; 3 PoC; 2 Phase II, and 15 Clinical Pharmacology studies Central role in study design, protocol writing, data analysis, and reportingRepresentative at FDA End of Phase 1 Meeting, Due Diligences (2), Drug Investment Boards (2), and Clinical Investigators Meetings (3)

Oct 2003 - Jan 2008

Pharmacy Practice Resident

University Of Kentucky Hospital
1997 - 1998 ~1 yr
2 education records

Christopher Matheny education

Phd, Pharmaceutics

University Of North Carolina At Chapel Hill

Residency, Clinical Pharmacy Practice

University Of Kentucky
FAQ

Frequently asked questions about Christopher Matheny

Quick answers generated from the profile data available on this page.

What company does Christopher Matheny work for?

Christopher Matheny works for INOVIO Pharmaceuticals, Inc..

What is Christopher Matheny's role at INOVIO Pharmaceuticals, Inc.?

Christopher Matheny is listed as VP, Development Leader | Rare Disease, Oncology, Immuno-Inflammation | Clinical Development at INOVIO Pharmaceuticals, Inc..

What is Christopher Matheny's email address?

AeroLeads has found 1 work email signal at @candeltx.com for Christopher Matheny at INOVIO Pharmaceuticals, Inc..

What is Christopher Matheny's phone number?

AeroLeads has found 3 phone signal(s) with area code 484, 208 for Christopher Matheny at INOVIO Pharmaceuticals, Inc..

Where is Christopher Matheny based?

Christopher Matheny is based in King Of Prussia, Pennsylvania, United States while working with INOVIO Pharmaceuticals, Inc..

What companies has Christopher Matheny worked for?

Christopher Matheny has worked for Inovio Pharmaceuticals, Inc., Cunningham & Matheny Llc, Candel Therapeutics, Glaxosmithkline, and University Of North Carolina At Chapel Hill.

How can I contact Christopher Matheny?

You can use AeroLeads to view verified contact signals for Christopher Matheny at INOVIO Pharmaceuticals, Inc., including work email, phone, and LinkedIn data when available.

What schools did Christopher Matheny attend?

Christopher Matheny holds Phd, Pharmaceutics from University Of North Carolina At Chapel Hill.

What skills is Christopher Matheny known for?

Christopher Matheny is listed with skills including Clinical Development, Clinical Research, Clinical Pharmacology, Biopharmaceuticals, Pharmacokinetics, Clinical Trials, Immunology, and Oncology Clinical Research.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.